石四藥集團

02005
2.5650.00% ( 0.000 )
延遲 開市競價中: 11月16日 09:00:00

股東

全部股東

股東類型

  • 私人企業55.72%
  • 公眾及其他17.92%
  • 機構投資者15.44%
  • 個人與內幕人士10.92%

主要股東

主要股東 最新
股東
China Pharmaceutical Company Limited
32.18%9.31 億0.65%+1,890.00 萬
Sichuan Kelun Industry Group CO., LTD.
23.54%6.81 億0.06%+019/03/2026
Jiguang QuExecutive Chairman & CEO
10.07%2.91 億0.00%+0
UBS Asset Management AG
5.08%1.47 億0.24%+699.25 萬
E Fund Management Co., Ltd.
3.39%9,814.20 萬<0.01%+031/12/2025
Vanguard Capital Management, LLC
1.53%4,427.46 萬0.05%-131.60 萬30/09/2026
BlackRock, Inc.
0.93%2,693.24 萬0.02%+49.20 萬30/10/2026
Dimensional Fund Advisors LP
0.90%2,615.72 萬0.07%-198.86 萬30/10/2026
Fullgoal Fund Management Co. Ltd.
0.86%2,483.00 萬<0.01%+031/12/2025
Xuejun SuFormer Executive Director
0.84%2,441.60 萬0.00%+028/09/2026
Penghua Fund Management Co., Ltd.
0.42%1,215.97 萬<0.01%+031/12/2025
American Century Investment Management Inc
0.37%1,079.20 萬0.04%+123.40 萬30/09/2026
China Merchants Fund Management Company Ltd.
0.37%1,059.40 萬<0.01%+031/12/2025
Bosera Asset Management Co., Ltd.
0.21%612.80 萬<0.01%+031/12/2025
AustralianSuper Advice Pty Ltd
0.21%610.97 萬<0.01%+031/12/2025
China Asset Management Co. Ltd.
0.19%546.60 萬<0.01%+030/06/2025
Norges Bank Investment Management
0.16%460.32 萬0.17%-506.68 萬30/06/2026
UBS SDIC Fund Management Co., Ltd.
0.12%346.00 萬<0.01%+031/12/2025
LSV Asset Management
0.11%308.60 萬0.03%+75.40 萬30/09/2026
State Street Investment Management
0.10%285.10 萬0.03%+91.60 萬31/10/2026